Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Legato Legt Stock Better Than Industry Peers Price At 11.01 Up 0.05 20260404 Is Rush Rusha Stock Worth Buying Now Price At 66.90 Up 0.24 20260408 Will Liqtech International Liqt Stock Miss Expectations Price At 1.76 Down 10.05 20260406 Is Cal Resource Crc Stock Priced For Growth Crc Q4 Earnings Misses Estimates By 0.06 20260408 1 SGRY Surgery Partners Inc shares rise slightly despite large Q4 2025 EPS miss and modest year over year revenue growth FCNCO First Citizens BancShares Inc 5625 Series C Preferred delivers narrow Q4 2025 earnings beat shares edge higher today Santander BR BSBR Stock Why Growth at Reasonable Price Ticks Higher 20260418 How ON ON responds to market challenges Edges Higher 20260508 Flex and Teradyne Robotics Deepen Partnership for Intelligent Manufacturing Automation Dropbox Founder Drew Houston to Step Down as CEO Transition to Executive Chairman Rosenblatt Adjusts Price Target for Cisco Systems Potential Upside Ahead Consumer Sentiment Declines to Record Low in May Amid USIran Tensions and Inflation Fears Turkish Political Turmoil Police Raid Opposition Offices After Ouster of Leaders Dow Surges 600 Points SP 500 and Nasdaq Rally as Oil Declines and Bond Yields Retreat Ahead of Nvidia Earnings SKYT Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher IDYA Q1 2026 Earnings PreRevenue Biotech Misses EPS Estimates as RD Pipeline Progresses HIW Q1 2026 Earnings Massive EPS Surprise of 161 Drives Stock Rally NWS Q1 2026 Earnings EPS Beats Estimates as Digital Transformation Gains Traction Immunic Inc IMUX Q1 2026 Earnings EPS Misses Estimates on RD Investment Stock Rises 79 on Pipeline Optimism FLUT Q1 2026 Earnings EPS Slightly Below Estimates Shares Slip A Paradise Acquisition Corp Unit APADU Holds Steady at 100 Amid Neutral Trading Bridgeline Digital BLIN Climbs 224 Stock Approaches Key Resistance at 099 SuRo Capital Holds Steady Near Support as Price Edges Higher Rapport Therapeutics RAPP Slides Slightly as Stock Tests Key Support Zone Core Scientific Warrants CORZW Gain 216 as Resistance Test Approaches